TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Novavax AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
820,346
|
1,570,987
|
980,891 |
| Financial expenses |
680,115
|
772,273
|
428,853 |
| Earnings before taxes |
194,900
|
518,188
|
-111,565 |
| EBITDA |
223,770
|
536,993
|
-100,494 |
| Total assets |
3,615,737
|
3,747,809
|
3,593,711 |
| Current assets |
205,513
|
2,637,429
|
2,568,627 |
| Current liabilities |
1,318,942
|
1,661,167
|
2,080,331 |
| Equity capital |
2,296,795
|
2,086,642
|
1,513,380 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
195
|
167
|
0 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
63.5%
|
55.7%
|
42.1% |
| Turnover per employee |
4,207
|
9,407 | |
| Profit as a percentage of turnover |
23.8%
|
33.0%
|
-11.4% |
| Return on assets (ROA) |
24.2%
|
34.4%
|
8.8% |
| Current ratio |
15.6%
|
158.8%
|
123.5% |
| Return on equity (ROE) |
8.5%
|
24.8%
|
-7.4% |
| Change turnover |
-750,641
|
590,096
|
585,715 |
| Change turnover % |
-48%
|
60%
|
148% |
| Chg. No. of employees |
28
|
167
|
-57 |
| Chg. No. of employees % | 17% | -100% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.